Abbvie Inc

Abbvie Inc

ABBV

Market Cap$302.21B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Abbvie IncAbbvie Inc50.83.53%-5.7-

Earnings Call Q1 2024

April 26, 2024 - AI Summary

AbbVie reported strong first quarter results, with adjusted earnings per share of $2.31, exceeding expectations.
Total net revenues were $12.3 billion, driven by the growth of their ex-Humira portfolio, which saw revenue growth of over 15%.
The company raised its full-year adjusted earnings per share guidance to between $11.13 and $11.33, reflecting a positive outlook for the year.

Exclusive for Stockcircle Pro members

Sign upSign Up
$191.29

Target Price by Analysts

11% upsideAbbvie Target Price DetailsTarget Price
$175.52

Current Fair Value

1.9% upside

Undervalued by 1.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$302.21 Billion
Enterprise Value-
Dividend Yield$6.0468 (3.53%)
Earnings per Share$3.36
Beta0.32
Outstanding Shares1,765,867,781
Avg 30 Day Volume6,240,396

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio50.78
PEG10.24
Price to Sales5.74
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Abbvie Inc

CEO: Richard Gonzalez